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PKCg promotes a proliferation to differentiation switch
in keratinocytes via upregulation of p27
Kip1 mRNA
through suppression of JNK/c-Jun signaling under
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To maintain epidermal homeostasis, the balance between keratinocyte proliferation and differentiation is tightly controlled.
However, the molecular mechanisms underlying this balance remain unclear. In 3D organotypic coculture with mouse
keratinocytesandﬁbroblasts,thethicknessofstratiﬁed celllayers wasprolonged,andgrowtharrest andterminaldifferentiation
were delayed when PKCg-null keratinocytes were used. Re-expression of PKCg in PKCg-null keratinocytes restored stratiﬁed
cell layer thickness, growth arrest and terminal differentiation. We show that in 3D cocultured PKCg-null keratinocytes, p27
Kip1
mRNAwasdownregulated,whereasJNK/c-Junsignalingwasenhanced.Furthermore,inhibitionofJNK/c-JunsignalinginPKCg-
nullkeratinocytesledtoupregulationofp27
Kip1mRNA,andtothinnerstratiﬁedcelllayers.Collectively,ourﬁndingsindicatethat
PKCg upregulates p27
Kip1 mRNA through suppression of JNK/c-Jun signaling. This results in promoting a proliferation to
differentiation switch in keratinocytes.
Cell Death and Disease (2011) 2, e157; doi:10.1038/cddis.2011.40; published online 19 May 2011
Subject Category: Cancer
The epidermis is a stratiﬁed squamous epithelium consisting
of a basal layer, a suprabasal layer, a granular layer and a
stratum corneum.
1 The keratinocytes in the basal layer have
proliferative potential and are undifferentiated. On terminal
differentiation, basal keratinocytes exit from the cell cycle and
subsequently move into the suprabasal layers. Exit from the
cell cycle and terminal differentiation are closely linked and
the balance between keratinocyte proliferation and differen-
tiation must be tightly controlled to maintain epidermal
homeostasis.
1
Changes in many processes, such as gene expression,
control keratinocyte proliferation and differentiation.
2 Of these
changes, upregulation of CDK inhibitors (CKI) p21
Cip1/WAF1
and p27
Kip1 is associated with keratinocyte growth arrest and
onsetofterminaldifferentiation.
3,4Emergingevidencereveals
that several signaling pathways, including those of Notch and
calcineurin, and transcription factors, such as Sp1/Sp3 and
NFAT, regulate the induction of p21
Cip1/WAF1 mRNA.
4–6 In
contrast, the molecular mechanisms underlying the induction
of p27
Kip1 during keratinocyte growth arrest and onset of
terminal differentiation are poorly understood.
PKC is also involved in keratinocyte proliferation and
differentiation.
7,8 PKCZ was originally cloned from a mouse skin
cDNA library.
9 Overexpression of PKCZ induces differentiation
of human and mouse keratinocytes.
10,11 Previously, we have
reported that PKCZ-null mice show normal skin development,
but PKCZ-null mice display prolonged epidermal hyper-
plasia after topical 12-O-tetradecanoylphorbol-13-acetate (TPA)
treatment and during re-epithelialization after skin injury.
12
Furthermore, PKCZ-null mice are susceptible to tumor
formation via a two-stage skin carcinogenesis protocol; a
single application of 7,12-dimethylbenz(a)anthracene for
tumor initiation followed by TPA treatment for tumor promo-
tion.
12 However, the regulation of keratinocyte proliferation,
differentiation and tumor formation by PKCZ remains unclear
and requires detailed study.
Because PKCZ is mainly expressed in the suprabasal and
granular layers of the epidermis,
13,14 the use of monolayer-
cultured keratinocytes is insufﬁcient to elucidate a function of
PKCZ. Furthermore, although in vivo studies provide valuable
insight into keratinocyte proliferation and differentiation, the
complex regulation of this phenomenon is difﬁcult to analyze,
because the interactions between keratinocytes and other
cells, such as inﬂammatory and immune cells, need to be
considered.
15,16 To elucidate a function of PKCZ in keratino-
cytes, it is, therefore, necessary to induce keratinocyte
stratiﬁcation in culture.
The 3D organotypic coculture of keratinocytes with dermal
ﬁbroblastscanbeusedtoinducestratiﬁcationandtoelucidate
the molecular mechanisms underlying keratinocyte prolifera-
tion and differentiation, and to understand the interactions of
keratinocytes withﬁbroblasts.
17 The3D organotypiccoculture
is also useful to understand re-epithelialization during wound
healing.
18 Although many studies using human keratinocytes
in 3D coculture have been reported, studies using genetically
deﬁned primary mouse keratinocytes and ﬁbroblasts are
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19,20 It is important to use primary mouse keratinocytes
and ﬁbroblasts in 3D coculture to enable the use of transgenic
and knockout mice.
In this study, we used a 3D organotypic coculture system
with primary mouse keratinocytes and ﬁbroblasts that we
have recently developed,
21 and we investigated the role of
PKCZ on epidermal keratinocyte proliferation and differentia-
tion. We provide evidence that PKCZ promotes keratinocytes
to switch from proliferation to differentiation via the induction
of p27
Kip1 mRNA through the suppression of JNK/c-Jun
signaling.
Results
The thickness of stratiﬁed cell layers produced using
PKCg-null keratinocytes was prolonged in 3D
organotypic coculture. To elucidate a possible role of
PKCZ in keratinocytes, we performed 3D organotypic
coculture. Because PKCZ is not expressed in the dermis,
13
we have used dermal ﬁbroblasts from wild-type (WT)
newborn mice. Dermal ﬁbroblasts were embedded in a gel
of type-I collagen within a hanging-drop insert. Keratinocytes
isolated from WT and PKCZ-null (KO) mice were overlaid
onto the surface of the gel. To induce keratinocyte
stratiﬁcation, the gel surface was raised to the air–liquid
interface by lowering the medium.
After air exposure, WT keratinocytes gradually stratiﬁed,
and by day 3 had formed multiple nucleated cell layers,
resembling the mouse epidermis under hyperplasia
(Figure1a).ThethicknessoftheupperWTcelllayergradually
decreased to 28±1mm (mean±S.E.M.) by day 5 and to
22±2mm by day 7 (Figure 1b). KO keratinocytes also
stratiﬁed, and by day 3 had formed multiple nucleated cell
layers, which were very similar to those of WT cells (Figures
1a and b). However, on day 5, the thickness of the upper KO
cell layer was 41±2mm, which was signiﬁcantly more than
that of WT cells (Po0.01). On day 7, the thickness of the KO
cells was 27±4mm, which was not signiﬁcantly different from
that of the WT cells. In addition, on day 4 and 6, and later at
day 7, no difference was observed between WT and KO cells
(data not shown). KO keratinocytes produced prolonged thick-
ness of stratiﬁed cell layers in 3D coculture, which resembled the
prolonged epidermal hyperplasia seen in KO mice.
12
We next re-expressed PKCZ in KO keratinocytes in 3D
coculture using a recombinant adenoviral vector (Ad-PKCZ).
On day 2, PKCZ re-expression in KO cells produced
comparable or slightly greater levels of PKCZ expression
relative to WT (Figures 1c and 5d). The thickness on day 5 of
the upper keratinocyte layer of WT and KO cells infected with
empty vector was 28±3 and 40±3mm, respectively (Figures
1d and e). In contrast, the thickness of the upper keratinocyte
layer of KO cells infected with Ad-PKCZ was 31±2mm on day
5,which wasalmost thesameasthatof WT cellsinfectedwith
empty vector. These results indicate that prolonged thickness
of stratiﬁed cell layers produced using KO keratinocytes is
caused by the loss of PKCZ.
PKCg promotes keratinocyte growth arrest. We next
examined the effects of PKCZ loss on keratinocyte DNA
synthesis using the BrdU labeling assay. In WT cells, on days
1 and 2, the BrdU-labeling index in the lowest layer was
about 50–60%, which was comparable with that in KO
cells (Figures 2a and b). On day 3, the labeling index in WT
cells decreased to 22%, indicating that keratinocytes underwent
growth arrest from day 2 to day 3. In contrast, in KO cells, the
labeling index was 39%, which was more than that in WT cells.
On day 5, the labeling index in KO cells was not signiﬁcantly
different from that in WT cells. When PKCZ was re-expressed in
KO keratinocytes by Ad-PKCZ, the labeling index on day 3 was
25%, which was almost the same as that in WT cells infected
with empty vector (Figures 2c and d).
In addition, we examined DNA synthesis in cultured
monolayer keratinocytes after changing the medium to one
containing a high Ca
2þ concentration ([Ca
2þ]), which
induces keratinocyte growth arrest and differentiation. In low
[Ca
2þ] medium, the labeling index was similar between WT
and KO cells (Figure 3a). After keratinocytes were exposed
to high [Ca
2þ] medium, the labeling index in WT cells
decreased. In contrast, the labeling index in KO cells rem-
ained higher (Figures 3a and b). Collectively, these results
indicate that PKCZ promotes keratinocyte growth arrest.
PKCg triggers keratinocyte terminal differentiation. Because
KO keratinocytes showed growth arrest delay, PKCZ may trigger
keratinocyte terminal differentiation. To address this question,
we examined expression of keratinocyte differentiation markers
in 3D coculture. In the epidermis, keratin 1 (K1) is an early
differentiation marker expressed in the suprabasal layer.
Upregulation of K1 is associated with the onset of keratinocyte
differentiation. Loricrin is a late differentiation maker expressed in
the granular layer. Keratin 5 (K5) is a marker of the basal layer.
Levels of K1 and loricrin in KO cells in 3D coculture were
decreased (Figure 4a). K5 was expressed throughout the upper
keratinocyte layer, which is similar to that seen in re-
epithelialization during wound healing.
22 K5 was not different
between WT and KO cells. Immunoblot analysis also showed
that K1 and loricrin, but not K5, were decreased in KO cells on
day 3 (Figure 4b). On day 2, K1 and loricrin in KO cells were at
comparable levels with those in WT cells (Figure 4c). These
results suggest that in KO keratinocytes, terminal differentiation is
delayed, but not blocked. When PKCZ was re-expressed in KO
keratinocytes by Ad-PKCZ, K1 and loricrin on day 3 were at
similar levels compared with those in WT cells infected with
empty vector (Figure 4d).
We also examined the induced level of K1 in cultured
monolayer keratinocytes in high [Ca
2þ] medium. The
expression level of K1 was low and similar between WT and
KO cells in low [Ca
2þ] medium (Figure 4e). K1 was markedly
induced in WT cells after exposure to high [Ca
2þ] medium
(Figure 4e). In contrast, K1 was weakly induced in KO cells.
PKCZ was also induced in keratinocytes exposed to high
[Ca
2þ] medium, as previously reported.
7 When PKCZ was
re-expressed in KO cellsby Ad-PKCZ,the induction ofK1 was
at similar levels compared with that in WT cells infected with
empty vector (Figure 4f). Collectively, these results indicate
that PKCZ triggers keratinocyte terminal differentiation.
PKCg upregulates p27
Kip1 mRNA in keratinocytes. To
explore the molecular mechanisms of PKCZ’s role in growth
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Cell Death and Diseasearrest and differentiation, we ﬁrst focused on expression
of CKI genes, which are important for cell growth arrest.
Because keratinocytes underwent growth arrest from day 2
to day 3, we examined mRNA levels in 3D coculture of
keratinocytes on day 2. We found that p27
Kip1 mRNA levels
in KO cells were reduced (Figure 5a). Expression levels in
KO cells of other CKI genes, including p21
Cip1/WAF1, were
comparable with those in WT cells (Figure 5a and
Supplementary Figure S1a). We also examined the mRNA
levels of genes that are important for keratinocyte
proliferation and differentiation (Supplementary Figure
S1b). The expression levels of these genes were similar
between WT and KO cells.
We examined time-dependent changes in p27
Kip1 and
p21
Cip1/WAF1 mRNA levels after air exposure. p27
Kip1 mRNA
in WT keratinocytes was upregulated from day 1 to day 2 and
downregulated from day 2 to day 3 (Figure 5b). In contrast,
p27
Kip1mRNAinKOcellswasnotinducedonday2.Onday3,
p27
Kip1 mRNA in KO cells was slightly reduced, but was not
signiﬁcantly different compared with that in WT cells
(P40.06). Levels of p21
Cip1/WAF1 mRNA in WT and KO cells
were similarly decreased from day 1 to day 3.
Immunoblot analysis showed that the level of p27
Kip1, but
not p21
Cip1/WAF1, was reduced in KO keratinocytes
(Figure 5c). When PKCZ was re-expressed in KO keratino-
cytes by Ad-PKCZ, the level of p27
Kip1 protein was restored to
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Figure 1 The thickness of stratiﬁed cell layers was prolonged using KO keratinocytes in 3D organotypic coculture. (a) Hematoxylin and eosin-stained sections of 3D
coculture after air exposure. Bar, 50mm. (b) Time-dependent change in thickness of upper layer. Five independent experiments were performed (n¼5); *Po0.01.
(c)ImmunoblotanalysisofPKCZlevelsinkeratinocytesofday23DcocultureinfectedwithemptyvectororAd-PKCZ.(d)Hematoxylinandeosin-stainedsectionsofday53D
coculture infected with Ad-PKCZ or empty vector. Bar, 50mm. (e) Thickness of upper layer of day 5 3D coculture infected with Ad-PKCZ or empty vector. Five independent
experiments were performed (n¼5); *Po0.01
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Cell Death and Diseasealmost the same level as that in WT cells infected with empty
vector(Figure 5d).CDK2, CDK4andcyclinD1, whichare also
required for keratinocyte proliferation,
23–25 were at similar
levelsinWTandKOcells(SupplementaryFigureS2a).These
results indicate that PKCZ upregulates p27
Kip1 mRNA in
keratinocytes.
We also examined induction of p27
Kip1 in cultured mono-
layer keratinocytes after changing in the medium to one
containing a high [Ca
2þ]. The level of p27
Kip1 protein was
markedly increased in WT cells, but weakly induced in KO
cells(Figure5e).WhenPKCZwasre-expressedinKOcellsby
Ad-PKCZ, the induction of p27
Kip1 was at similar levels
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Figure 2 PKCZ promotes keratinocyte growth arrest in 3D coculture. (a) Immunostaining of BrdU in sections of 3D coculture. Arrows indicate BrdU-labeled cells. Bar,
50mm. (b) BrdU-labeling index in the lowest layer. Five independent experiments were performed (n¼5); *Po0.01. (c) Immunostaining of BrdU in sections of day 3 3D
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Figure 3 PKCZ promotes keratinocyte growth arrest in cultured monolayer keratinocytes in high [Ca
2þ] medium. (a) BrdU immunostaining of monolayer-cultured
keratinocytes after the medium was changed to one containing high [Ca
2þ] and culture continued for 18h. Bar, 50mm. (b) Relative percentages of BrdU-labeled cells in
keratinocytes exposed to high [Ca
2þ] medium. Relative % denotes percentages of BrdU-labeled cells in high [Ca
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were counted. Three independent experiments were performed (n¼3); *Po0.01
K1
K1
PKCη
p27
K5
WT+control KO+Ad-PKCη
K5
(67 kD)
(57 kD)
(60 kD)
(42 kD)
K5
DAPI
Loricrin
DAPI
WT KO
WT KO
(67 kD)
(57 kD)
(42 kD)
0 12 24 0 12 24
01 22 4012 24 0 12 24 Ca2+ treatment (h)
Ca2+ treatment (h)
WT KO
PKCη
WT KO
Actin
Loricrin
K1
(67 kD)
(60 kD)
(82 kD)
(67 kD)
(82 kD)
(27 kD)
(60 kD)
Actin
Loricrin
K1
K1
DAPI
Loricrin
DAPI
K1
DAPI
KO+control
WT+control KO+Ad-PKCη KO+control
K5
Figure 4 PKCZ triggers keratinocyte terminal differentiation. (a) Immunostaining of K5, K1 and loricrin in sections of 3D coculture on day 3. Bar, 25mm. (b) Immunoblot
analysisof K5, K1and loricrin levelson day 3. Representativeresultsare shown. (c) Levelsof K1and loricrinon day 2. (d)Immunostaining of K1and loricrin in sectionsof 3D
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Kip1 and PKCZ in cultured monolayer keratinocytes infected with Ad-PKCZ or empty vector in high [Ca
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Cell Death and Diseasecompared with that in WT cells infected with empty vector
(Figure 4f).
PKCg suppresses JNK/c-Jun signaling in
keratinocytes. To determine how PKCZ upregulates p27
Kip1
expression on day 2, we examined MAPK signaling,
1,24,26,27
EGFR signaling
1,26 and NF-kB signaling,
1,2,24 which are
important for keratinocyte proliferation and differentiation
(Figure 6a and Supplementary Figure S2b). We found that
phosphorylated (activated) JNK was elevated in KO
keratinocytes. Furthermore, phosphorylated c-Jun, which is
downstream of JNK, was also elevated in KO cells. Total JNK
and c-Jun in KO cells were at similar levels to those in WT
cells. When PKCZ was re-expressed in KO keratinocytes by
Ad-PKCZ, phosphorylated JNK and c-Jun were restored to
similar levels compared with those in WT cells infected with
empty vector (Figure 6b). These results indicate that PKCZ
suppresses JNK/c-Jun signaling in keratinocytes.
JNK/c-Jun signaling upregulates p27
Kip1 mRNA in
keratinocytes. We next determined whether upregulation
of JNK/c-Jun signaling in KO keratinocytes leads to
downregulation of p27
Kip1 expression on day 2. We
examined the expression of p27
Kip1 in KO cells treated with
SP600125, a JNK-speciﬁc protein kinase inhibitor. When the
level of phosphorylated c-Jun in KO cells treated with
SP600125 was comparable with that in WT cells, the levels
of p27
Kip1 protein and mRNA were restored to levels
comparable with those in WT cells (Figures 6c and d).
Furthermore, on day 5, the thickness of the upper
keratinocyte layer in KO cells treated with SP600125 was
not different from that in WT cells (Figures 6e and f).
Collectively, these results indicate that PKCZ suppresses
JNK/c-Jun signaling, which leads to the induction of p27
Kip1
mRNA.
Discussion
In this study, using 3D organotypic coculture with mouse
primary keratinocytes and ﬁbroblasts, we found that in PKCZ-
null (KO) keratinocytes, the thickness of stratiﬁed cell-layers
was prolonged, and growth arrest and terminal differentiation
were delayed. Furthermore, in KO keratinocytes exposed to
high [Ca
2þ], growth arrest and terminal differentiation were
delayed. In KO keratinocytes, p27
Kip1 mRNA was down-
regulated, whereas JNK/c-Jun signaling was enhanced.
Inhibition of JNK/c-Jun signaling leads to upregulation of
p27
Kip1 mRNA and to thinner stratiﬁed cell layers in KO
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Cell Death and Diseasekeratinocytes. Our ﬁndings provide molecular links among
PKCZ,upregulationofp27
Kip1mRNAandJNK/c-Junsignaling
in keratinocytes.
Overexpression of PKCZ in human keratinocytes partially
inhibits DNA synthesis and induces epidermal transglutami-
nase, which is involved in the crosslinking of proteins in the
outermost epidermal layers, but does not change the
expression of K1 and loricrin.
10 Similarly, overexpression of
PKCZ in mouse keratinocytes partially inhibits DNA synthesis
and induces epidermal transglutaminase,
11 suggesting that
PKCZ functions during late events of keratinocyte terminal
differentiation. On the basis of our ﬁndings, PKCZ promotes
keratinocyte growth arrest and triggers terminal differentia-
tion. Taken together, PKCZ has dual functions in keratino-
cytes; a trigger for transition from the proliferation state to
the differentiation state, and a late function in terminal
differentiation.
Overexpression of a constitutively active form of PKCZ
stimulates JNK activation in HEK293 cells.
28 In contrast,
induciblePKCZexpressioninMCF-7cellsinhibitsJNKactivity
and apoptosis in response to DNA damage.
29 Molecular
mechanisms underlying the regulation of JNK/c-Jun signaling
byPKCZ may be dependent on physiological conditions, or be
cell-type speciﬁc. Further studies are required to elucidate the
molecular mechanisms underlying the negative regulation of
JNK activity by PKCZ during the switch from proliferation to
differentiation in keratinocytes.
What factors are upstream of PKCZ during keratinocyte
growth arrest and differentiation? Because TGFb signaling
induceskeratinocytegrowtharrest,
30weexaminedtheeffects
of loss of PKCZ on TGFb1-induced growth arrest in cultured
monolayer keratinocytes. However, the growth arrest in WT
and KO keratinocytes was similarly induced after TGFb1
treatment (data not shown). Furthermore, expression of
p15
Ink4b, Mad1 and c-Myc, target genes of TGFb signal-
ing,
30,31 was not different between WT and KO keratinocytes
in 3D coculture on day 2 (Supplementary Figure S1a). Our
ﬁndings suggest that TGFb does not act upstream of PKCZ to
induce keratinocyte growth arrest. Alternatively, a high
extracellular [Ca
2þ] would at least act upstream of PKCZ,
because KO cultured monolayer keratinocytes exposed to a
high [Ca
2þ] had delayed growth arrest and terminal differ-
entiation. Increased extracellular [Ca
2þ] induces increased
intracellular [Ca
2þ] and phosphatidylinositol turnover in
keratinocytes.
5,32 PKCZ is activated by diacylglycerol, but
not Ca
2þ and diacylglycerol is produced by phosphatidyl-
inositol turnover.
32
p27
Kip1 is an important regulator of cell growth arrest and
terminal differentiation in other cell types, such as oligoden-
drocytes and erythroid cells.
33,34 Furthermore, p27
Kip1 and
Mad1 cooperate to control self-renewal and differentiation of
hematopoietic stem cells.
35 It would be interesting to
determine whether PKCZ has a function for cell growth arrest
and terminal differentiation in other cell types, such as
oligodendrocytes or erythroid cells.
Regulation of p27
Kip1 has been shown to be primarily
controlled at the protein level instead of the mRNA level.
36
However,accumulatingevidenceindicatesthatp27
Kip1isalso
regulated at the mRNA level.
37 On the basis of our ﬁndings,
PKCZ upregulates p27
Kip1 mRNA in keratinocytes. What kind
of transcriptional factor functions in keratinocytes? c-Jun is a
member of transcriptional factor AP-1 family, which consists
of various dimmers of the Fos, Jun and CREB/ATF families.
38
AP-1 has an important role in regulating keratinocyte
proliferation and differentiation.
38 For example, AP-1 regu-
lates numerous genes, including EGFR, several keratins,
involucrin and loricrin.
26,38 In addition, AP-1 inactivation in the
suprabasal epidermis causes increased epidermal hyperpro-
liferation, delayed differentiation and hyperkeratosis.
39 c-Jun
in combination with binding partners has a function in
regulating the promoter activity positively or negatively.
c-Jun binds directly to the AP-1 element at  469 in the
human p27
Kip1 promoter and represses p27
Kip1 transcription
in HEK293 and Huh7 cell lines.
37 It is necessary to determine
whether c-Jun directly represses the expression of p27
Kip1 in
keratinocytes. However, using a chromatin immunoprecipita-
tion assay with samples from 3D coculture, we did not detect
binding of c-Jun to TPA- or cAMP-response elements, which
are located within 3kb upstream from the transcription
initiation site, in exon 1 and intron 1 of p27
Kip1 gene (data
not shown). c-Jun may indirectly repress the expression of
p27
Kip1 and may regulate the expression of the other
transcription factors such as C/EBP, AP2, Id3, Sp1 and NFAT
in keratinocytes.
1,2,5,6 These transcriptional factors may
repress the expression of p27
Kip1. Further studies are
required to elucidate the molecular mechanisms underlying
the repression of p27
Kip1.
Keratinocytes cultured in high [Ca
2þ] medium do not show
JNK activation.
27 On the basis of our ﬁndings, phosphorylated
JNK was not induced in WT- and KO-monolayer-cultured
keratinocytes exposed to high [Ca
2þ] medium (data not
shown).However,whenkeratinocyteswereinducedtostratify
in culture, phosphorylated JNK was elevated in KO cells. This
discrepancy may account for the high levels of phosphory-
lated JNK seen in WT- and KO-monolayer-cultured keratino-
cytes in low [Ca
2þ] medium (data not shown). Thus, 3D
cocultureisnecessarytoelucidatethemolecularmechanisms
underlying keratinocyte proliferation and differentiation.
Inﬂammatory and immune cells inﬂuence keratinocyte
proliferation and differentiation under stress conditions, such
as the inﬂammation response and wound healing.
15,16 These
cells may modulate keratinocyte proliferation in PKCZ-null
mice, which display prolonged epidermal hyperplasia. How-
ever, in vivo studies alone could not determine a function of
PKCZ in keratinocyte proliferation and differentiation in a
keratinocyte-autonomous manner, because inﬂammatory
and immune cells had to be considered. On the basis of our
ﬁndings, that KO keratinocytes produced prolonged thickness
of stratiﬁed cell layers in 3D coculture, we suggest that PKCZ
regulates keratinocyte proliferation and differentiation in a
keratinocyte-autonomous manner.
We hypothesize that PKCZ functions in the epidermis as
shown in Figure 6g. PKCZ-null mice show normal skin
development; therefore, under normal conditions in the
epidermis, PKCZ is not essential for proliferation and
differentiation.
12 Under stress conditions, such as the
inﬂammation response and wound healing, keratinocytes
are induced into a hyperproliferative state. In the transition
from the hyperproliferative state to the normal state, PKCZ
functions in the transition from proliferation to differentiation.
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Kip1 expression
through the suppression of JNK/c-Jun signaling. However,
furtherstudiesarerequiredtounderstandtheroleofp27
Kip1in
epidermis. We propose that PKCZ is an important regulator of
the proliferation–differentiation switch in keratinocytes during
the inﬂammatory response and wound healing, but not in
normalskindevelopment,throughtheregulationofJNK/c-Jun
signaling and p27
Kip1. Furthermore, we also propose that
PKCZ suppresses skin tumor formation through regulation of
the keratinocyte proliferation–differentiation switch.
In conclusion, we provide evidence that PKCZ promotes
transition of keratinocyte proliferation to differentiation via the
upregulation of p27
Kip1 mRNA through suppression of JNK/
c-Jun signaling.
Materials and Methods
Mice. PKCZ-null (Prkch / ) mice were generated as reported previously.
12
They were backcrossed to C57BL/6J through 13 generations. All animal
experiments were performed in accordance with the policies of the Animal Ethics
Committee of The University of Tokyo.
Antibodies. Primary antibodies were as follows: K5, K1 and loricrin (Covance,
Berkeley, CA, USA); cyclin D1 (72-13G), phospho-EGFR (Tyr 1173; sc-12351),
PKCZ (sc-215), c-Jun (sc-45), p21 (sc-397) and p27 (sc-528; Santa Cruz, Santa
Cruz, CA, USA); phospho-Akt (Ser473), Akt, EGFR, phospho-Erk (Thr202/Tyr204),
Erk, phospho-IKKa (Ser180)/IKKb (Ser181), IKKa, IKKb,I kBa, phospho-JNK
(Thr183/Tyr185),JNK,phospho-c-Jun(Ser63),phospho-p38(Thr180/Tyr182),p38,
phospho-p65 (Ser536) and p65 (Cell Signaling Technology, Beverly, MA, USA);
CDK2 and CDK4 (Transduction Laboratories, San Diego, CA, USA); b-actin
(AC-15) and a-tubulin (B-5-1-2; Sigma, Saint Louis, MO, USA); BrdU (BMG 6H8,
Roche, Mannheim, Germany). Secondary antibodies conjugated with alkaline
phosphatase for immunoblot analysis were purchased from Chemicon (Temecula,
CA, USA). Secondary antibodies conjugated with Alexa Fluor 488 or Alexa Fluor
594 was purchased from Invitrogen (Carlsbad, CA, USA).
Construction of recombinant adenoviral vectors. Recombinant
adenoviral vectors were constructed as previously described.
40 Brieﬂy, the
mouse Prkch cDNA was subcloned into the pKSCX-EGFP vector. The Prkch
expression cassette was inserted into the SwaI site of the pALC3 cosmid to make
pALC3-PKCZ.TherecombinantadenoviralvectorencodingPrkchwasproducedby
transfecting HEK293T cells with pALC3-PKCZ and pMC1-Cre. The empty vector
(for use as a control) was produced by infecting HEK293T cells with pALC3 and
pMC1-Cre.ThetiterofvirusstockswasdeterminedwiththeAdeno-XRapidTiterKit
(Clontech, Palo Alto, CA, USA) according to the manufacturer’s instructions.
Cell isolation and culture. Epidermal keratinocytes and dermal ﬁbroblasts
wereisolated fromthedorsalskin of1- to3-day-old mice,andcultured asdescribed
previously.
21 Brieﬂy, the epidermis was incubated in a 0.1% collagenase solution
(Worthington, Lakewood, NJ, USA) in MCDB153 medium (Sigma) supplemented
with 10% dialyzed FCS (dFCS) overnight at 41C. After removal of the dermis,
keratinocytes were isolated and used as primary keratinocytes. Almost all the cells
isolated from the epidermis expressed cytokeratin but not vimentin.
21 In monolayer
cultures, isolated keratinocytes were plated at 1.5 10
6 cells/35mm dish or at
5 10
5 cells/well in collagen I (BD Biosciences, San Jose, CA, USA) -coated
12-well plastic plates, and cultured in MCDB153 supplemented with 10% dFCS. To
induce keratinocyte differentiation, the [Ca
2þ] of the media was raised from 0.03 to
0.5mMbyaddingCaCl2onday3afterplating.Adenovirusinfectionofkeratinocytes
was carried out on day 1 after plating for 3h in MCDB153 supplemented with 10%
dFCS. Adenoviral infections were performed at an MOI of ﬁve.
Fibroblasts were isolated from the remaining dermis, cultured in DMEM (Nissui,
Tokyo, Japan) supplemented with 10% FCS, passaged two times to achieve a
homogenous population of spindle cells and used for organotypic coculture.
Organotypic coculture. Primary keratinocytes and dermal ﬁbroblasts,
isolated as described above, were used to reconstruct the dermal equivalent, as
described previously with slight modiﬁcations.
21 Brieﬂy, primary keratinocytes were
seeded (8 10
5 cells/insert in a 12-well plate) onto collagen type I gels (Nitta
Gelatin, Osaka, Japan) containing 9.1 10
4 per ml primary ﬁbroblasts and cultured
in MCDB 153 supplemented with 10% dFCS. After 24h, the culture medium was
replaced with a mixture of conditioned MCDB153 supplemented with 10% dFCS
and FAD medium (1:1 volume) and cultures incubated for 24h. The gel surface
was raised to the air–liquid interface by lowering the level of the FAD (to 0.8ml in
each well of a 12-well plate). FAD was replaced every 2 days. Adenovirus infection
(2.6 10
7p.f.u./insertina12-wellplate)wascarriedoutonday1afterseedingonto
collagen type I gels in a mixture of conditioned MCDB153 supplemented with 10%
dFCS and FAD (1:1 volume) for 24h. Treatment with SP600125 (100mM ﬁnal
concentration; Wako, Osaka, Japan) was carried out for 24h after air exposure on
day 1.
Histological analysis. Organotypic coculture samples were ﬁxed in 4%
formaldehyde/PBS at room temperature overnight and embedded in parafﬁn. The
samples (4mm thick) were deparafﬁnized with xyleneand ethanol,andthen stained
with hematoxylin and eosin according to standard procedures. Malinol (Muto Pure
Chemicals, Tokyo, Japan) was used as mounting medium. The epithelial thickness
without the corniﬁed layer was measured in at least 12 independent regions.
Immunoﬂuorescence histochemistry. Deparafﬁnized sections (4mm
thick) were washed three times with PBS. For K5, after deparafﬁnization, antigen
retrieval was performed by incubation in 10mM citrate buffer (pH 6.0) at 981C for
10min. Sections were blocked with 5% normal goat serum for 30min at room
temperature and then incubated with antibodies at 41C. After washing three times
with PBS containing 0.05% Tween-20, the sections were incubated with secondary
antibodyconjugatedwith AlexaFluor488 (Invitrogen)at 371C for 1h. After washing
three times with PBS containing 0.05% Tween 20, the sections were incubatedwith
DAPI (Wako)for 10min,washedtwotimeswith PBSandmountedwithPermaFluor
Mountant Medium (Thermo Shandon, Pittsburgh, PA, USA).
BrdU incorporation assay. For 3D organotypic coculture, BrdU (Sigma) at
65mM ﬁnal concentration was added to the FAD medium 4h before ﬁxation.
Deparafﬁnized sections (4mm thick) were washed with PBS three times, treated
withmethanol/H2O2(80/20%ofa3%H2O2solution)for20min,followedbywashing
with PBS three times, and then incubated with 0.25% trypsin at 371C for 5–15min.
AfterwashingwithPBSthreetimes,sectionsweretreatedwith2NHClfor10minat
room temperature, followed by three washes with PBS, and incubated with anti-
BrdU antibody conjugated with peroxidase at 371C for 2h. After washing with PBS
three times, DAB (Dako Japan, Kyoto, Japan) was used as chromogen.
Hematoxylin was used as a counterstain. Sections were mounted with
PermaFluor Mountant Medium (Thermo Shandon). At least 10 independent
regions were measured.
For monolayer-cultured keratinocytes, CaCl2 (0.5mM ﬁnal concentration) was
added to medium on day 3 after plating. At 18h after addition, cells were ﬁxed with
70% ethanol/15mM glycine solution (pH 2.0) for 20min at  201C. BrdU at 65mM
ﬁnal concentration was added to the medium 6h before ﬁxation. The assay was
performed with a 5-bromo-20-deoxyuridine Labeling and Detection Kit II (Roche)
according to the manufacturer’s instructions, except for the secondary antibody
used; antibody conjugated with Alexa Fluor 594 (Invitrogen) was used as the
secondaryantibody.NucleiwerestainedwithDAPI.Atleast10independentregions
were measured.
Immunoblot analysis. For 3D organotypic coculture, the upper keratinocyte
layer was physically separated from the collagen gels with forceps, treated with
standard SDS sample buffer and boiled at 981C for 5min. After centrifugation,
supernatants were subjected to SDS-PAGE. For monolayer-cultured keratinocytes
induced to differentiate by Ca
2þ, ﬂoating and adhered keratinocytes were treated
with SDS sample buffer and boiled at 981C for 5min. After centrifugation,
supernatants were subjected to SDS-PAGE. The separated proteins were
electrically blotted onto a nitrocellulose membrane. At least three independent
experiments were performed. Detection was performed using BCIP/NBT (Sigma)
substrates.
Real-time PCR analysis. Total RNAs were isolated from the upper
keratinocyte layer, physically separated from the collagen gels, or from
monolayer-cultured keratinocytes using TRIzol (Invitrogen) according to the
manufacturer’s instructions. cDNA was synthesized from 2mg of total RNA using
a ﬁrst strand synthesis kit (Roche) and random primers. The resulting cDNA (20ng)
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Biosystems, Foster City, CA, USA) in the ABI Prism 7900 Sequence Detection
System. The expression levels of all samples were normalized to an endogenous
control, Gapdh. Quantiﬁcation was carried out using the 2
 DDCt method. Primer
Sequences are shown in Supplementary Table S1.
Statistical analysis. All results are expressed as mean±S.E.M. The two-
tailed unpaired t-test was used for all experiments. P-values o0.05 were
considered statistically signiﬁcant.
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